Evolutionary Diversity as a Source for Anticancer Molecules

A new textbook entitled Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as a source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms.

The book goes over the isolation of anticancer agents and the technology-enabled screening process used to develop anticancer drugs. The book also includes discussion of the nutraceuticals and natural products derived from invertebrates that can be used as part of cancer treatment.

Evolutionary Diversity as a Source for Anticancer Molecules (ISBM 978-0-12-821710-8) also deals with some of the current challenges in the prevention of cancer as well as the side effects of conventional drugs used for cancer patients.

This book is a valuable resource for cancer researchers, oncologists, biotechnologists, pharmacologists, and any member of the biomedical field interested in understanding more about natural products with anticancer potential.

Upcoming Events

SHOT Report 2019: ADU highlights webinar

Online
28 January 2021

COVID-19 - The Infection that Challenged the World: Is Necessity the Mother of Invention?

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Upcoming Events

SHOT Report 2019: ADU highlights webinar

Online
28 January 2021

COVID-19 - The Infection that Challenged the World: Is Necessity the Mother of Invention?

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022